zabdeno
janssen-cilag international n.v. - recombinant adenovirus type 26 (ad26) encoding the glycoprotein (gp) of the ebola virus zaire (zebov) mayinga strain - Геморрагическая groznice ebole - cjepiva - active immunization for prevention of disease caused by ebola virus (zaire ebolavirus species) in individuals ≥ 1 year of age.
eurican dap
boehringer ingelheim animal health france scs, 29 avenue tony garnier, 69007 lyon,francuska - atenuirani virus štenećaka, soj ba5; atenuirani adenovirus pasa tip 2, soj dk13; atenuirani parvovirus pasa tip 2, soj cag2 - liofilizat i otapalo za suspenziju za injekciju - pasa
spiolto respimat 2,5 mikrograma/2,5 mikrograma, otopina inhalata
boehringer ingelheim international gmbh, binger straße 173, ingelheim am rhein, njemačka - tiotropijev bromid hidrat olodaterolklorid - otopina inhalata - 2,5 mcg/2,5 mcg - urbroj: jedna inhalacijska doza sadržava 2,5 mikrograma tiotropija (u obliku bromidhidrata) i 2,5 mikrograma olodaterola (u obliku klorida) po potisku
betaserc 16 mg tablete
viatris hrvatska d.o.o., koranska 2, zagreb, hrvatska - betahistindiklorid - tableta - 16 mg - urbroj: jedna tableta sadrži 16 mg betahistindiklorida
betaserc 24 mg tablete
viatris hrvatska d.o.o., koranska 2, zagreb, hrvatska - betahistindiklorid - tableta - 24 mg - urbroj: jedna tableta sadrži 24 mg betahistindihidroklorida.
zoonotic influenza vaccine seqirus
seqirus s.r.l. - zoonotic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted), influenza virus surface antigens (haemagglutinin and neuraminidase) of strain: a/turkey/turkey/1/05 (h5n1)-like strain (nibrg-23) - influenza a virus, h5n1 subtype - cjepiva - active immunisation against h5 subtype of influenza a virus.
suvaxyn circo+mh rtu
zoetis belgium sa - inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2 orf2 protein, inactivated mycoplasma hyopneumoniae, strain p-5722-3 - Инактивированные virusnih i инактивированные bakterijska cjepiva - svinje - za aktivne imunizacije svinja s 3 tjedna starosti protiv svinjske цирковирус tipa 2 (pcv2) za smanjenje količine virusa u krvi i лимфоидных tkiva i fekalne prolijevanja, uzrokovane infekcijom s ЦВС2. za aktivnu imunizaciju svinja u dobi od 3 tjedna protiv mycoplasma hyopneumoniae za smanjenje plućnih lezija uzrokovanih infekcijom s m. hyopneumoniae.
circomax myco
zoetis belgium - inactivated mycoplasma hyopneumoniae, strain p-5722-3, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2a open reading frame 2 (orf2) protein, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2b orf2 protein - imunološke za suidae - svinja (za tov) - active immunisation of pigs against porcine circovirus type 2 to reduce viral load in blood and lymphoid tissues, fecal shedding and the lesions in lymphoid tissues associated with pcv2 infection. protection was demonstrated against porcine circovirus types 2a, 2b and 2d. active immunisation of pigs against mycoplasma hyopneumoniae to reduce the lung lesions associated with mycoplasma hyopneumoniae infection. onset of immunity (both vaccination schedules): 3 weeks after (the last) vaccination. duration of immunity (both vaccination schedules): 23 weeks after (the last) vaccination. in addition, vaccination has been shown to reduce body weight gain losses under field conditions.
bimervax
hipra human health s.l. - sars-cov-2 virus recombinant spike (s) protein receptor binding domain (rbd) fusion heterodimer – b.1.351-b.1.1.7 strains - covid-19 virus infection - cjepiva - bimervax is indicated as a booster for active immunisation to prevent covid-19 in individuals 16 years of age and older who have previously received a mrna covid-19 vaccine.
unconstrained dimesions diameter 10mm, dual layer length 30mm, overall length 43mm
sonimed d.o.o. rozganska 8 10110 zagreb -